Electroporation-mediated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L gene therapy for hepatocellular carcinoma. (Q40664012)
Jump to navigation
Jump to search
scientific article published on January 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Electroporation-mediated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L gene therapy for hepatocellular carcinoma. |
scientific article published on January 2002 |
Statements
Electroporation-mediated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L gene therapy for hepatocellular carcinoma (English)
Yo-Ichi Yamashita
Mitsuo Shimada
Shinji Tanaka
Masahiro Okamamoto
Keizo Sugimachi
1 January 2002